Related Experiment Video
Updated: Jun 14, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots
Jian Liu1, Stephen K Lau, Vijay A Varma
1Department of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 2001, Atlanta, Georgia 30322, USA.
Abstract:
Tumor heterogeneity is one of the most important and challenging problems not only in studying the mechanisms of cancer development but also in developing therapeutics to eradicate cancer cells. Here we report the use of multiplexed quantum dots (QDs) and wavelength-resolved spectral imaging for molecular mapping of tumor heterogeneity on human prostate cancer tissue specimens. By using a panel of just four protein biomarkers (E-cadherin, high-molecular-weight cytokeratin, p63, and alpha-methylacyl CoA racemase), we show that structurally distinct prostate glands and single cancer cells can be detected and characterized within the complex microenvironments of radical prostatectomy and needle biopsy tissue specimens. The results reveal extensive tumor heterogeneity at the molecular, cellular, and architectural levels, allowing direct visualization of human prostate glands undergoing structural transitions from a double layer of basal and luminal cells to a single layer of malignant cells. For clinical diagnostic applications, multiplexed QD mapping provides correlated molecular and morphological information that is not available from traditional tissue staining and molecular profiling methods.
Insights
Multiplexed quantum dots (QDs) and spectral imaging reveal extensive tumor heterogeneity in prostate cancer tissues. This molecular mapping approach enhances understanding of cancer development and aids in developing targeted therapeutics.
Area of Science:
- Oncology
- Biomedical Imaging
- Molecular Pathology
Background:
- Tumor heterogeneity presents significant challenges in cancer research and therapeutic development.
- Understanding the molecular and cellular diversity within tumors is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the utility of multiplexed quantum dots (QDs) and spectral imaging for molecular mapping of tumor heterogeneity in human prostate cancer.
- To characterize distinct prostate glands and cancer cells within complex tissue microenvironments.
Main Methods:
- Utilized multiplexed quantum dots (QDs) for labeling protein biomarkers.
- Employed wavelength-resolved spectral imaging for molecular mapping of tissue specimens.
- Analyzed human prostate cancer tissue samples from radical prostatectomy and needle biopsies using a panel of four protein biomarkers (E-cadherin, high-molecular-weight cytokeratin, p63, and alpha-methylacyl CoA racemase).
Main Results:
- Demonstrated the detection and characterization of structurally distinct prostate glands and individual cancer cells.
- Revealed extensive tumor heterogeneity at molecular, cellular, and architectural levels.
- Visualized structural transitions of prostate glands from normal to malignant cell layers.
Conclusions:
- Multiplexed QD mapping provides correlated molecular and morphological information for analyzing tumor heterogeneity.
- This technique offers advantages over traditional tissue staining and molecular profiling methods for clinical diagnostic applications.
- The findings contribute to a deeper understanding of prostate cancer development and heterogeneity.
More Related Videos
06:51Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025
08:18Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples
Published on: April 7, 2023